Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative

Raf Bisschops, Miguel Areia, Emmanuel Coron, Ecaterina Daniela Dobru, Bernd Kaskas, Roman Kuvaev, Oliver Pech, Krish Ragunath, Bas L.A.M. Weusten, Pietro Familiari, Dirk Domagk, Roland Valori, Michal Filip Kaminski, Cristiano Spada, Michael Bretthauer, Cathy Bennett, Carlo Senore, Mario Dinis-Ribeiro, Matthew David Rutter

Presented by

Synopsis

The European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) have identified quality of endoscopy as a major priority and we described our rationale for this in a first manuscript that also addressed the methodology of the quality initiative process. The identification of upper gastrointestinal (UGI) performance measures presents a considerable challenge, in contrast to the situation with colonoscopy for instance, where several performance measures (inspection time, adenoma detection rate, and interval cancers, among others) have been identified over the last decade. Following the Quality in UGI Endoscopy meeting held in Lisbon in 2013, it was clear that there was a need to identify performance measures for the UGI tract, and that quality standards could be identified although there is a paucity of evidence. This lack of evidence helps however to identify research priorities for the development of clinical trials that will further validate and substantiate the implementation of performance measures. The aim therefore of the UGI working group was twofold: (a) to identify performance measures for UGI endoscopy; (b) to identify the evidence or absence of evidence that would develop the research priorities in this field. We used an innovative methodology to facilitate the quality initiative process, which combined a thorough search and standardized evaluation of the available evidence for each clinical question, followed by a Delphi process (http://is.njit.edu/pubs/delphibook/delphibook.pdf) using an online platform. This online platform permitted iterative rounds of modification and comment by all members of the UGI working group until agreement was reached on the performance measure. We now report these newly identified performance measures. 

ESGE and UEG have identified the quality of endoscopy as a major priority. UEG co-funded the ESGE quality improvement initiative and provided additional project governance.

Keywords: benign oesophageal strictures; single-center experience; high-grade dysplasia; superficial neoplastic lesions; nonampullary duodenal adenomas; randomized controlled-trial; Barrett's ooesophagus; balloon dilatation; anastomotic strictures; intestinal metaplasia

Available Languages

English

Source File

Publishing organization(s):

ESGE European Society of Gastrointestinal Endoscopy, United European Gastroenterology (UEG)

Scientific area:

Endoscopy
     
guideline_20359.pdf
Download poster as PDF.
guideline_20359.pdf


This item can be cited as: United European Gastroenterology Journal 2016, Vol. 4(5) 629–656; PMID 27733906

You may be interested in:

Early detection and endoscopic treatment
English, Presentation, Stomach & H. Pylori, 2016, Endoscopy, Histopathology, Surgery, Digestive Oncology
All patients with reflux symptoms should be screened for the presence of Barrett
English, Presentation, Oesophagus, 2015, Chairman's Choice, Endoscopy, Histopathology, Surgery, Digestive Oncology
ENDOSCOPIC RESECTION FOR MUCOSAL ESOPHAGEAL CANCER – IS THERE A DIFFERENCE IN OUTCOME BETWEEN MUCOSAL BARRETT’S CANCER AND MUCOSAL SQUAMOUS CELL CANCER?
English, Abstract, 2009

Categorisation:

  • Format
    • Standards and Guidelines
  • Language
    • English
  • UEG Member Society
    • European Society of Gastrointestinal Endoscopy (ESGE)
  • UEG Week Pathway
    • Endoscopy
    • Oesophagus
    • Stomach & H. Pylori
  • Year
    • 2016